Abstract 2929: Modular peptide cargo delivery by targeting CD40 enables ligandome driven, precision immunotherapy via the Adaptable Drug Affinity Conjugate (ADAC™) technology

Mebrahtu A, Lauren I, Veerman R, Kostakis A, Akpinar GG, Andersson O, Gudmundsdotter L, Furebring T, Persson H, Donnes P, Rockberg J, Mangsbo S

Cancer Res. 83 (7_Supplement) 2929-2929 [2023-04-04; online 2023-04-04]

DOI 10.1158/1538-7445.am2023-2929

Crossref 10.1158/1538-7445.am2023-2929